Condition
Pulpal Inflammation
Total Trials
4
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed2
Active Not Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07533396Not Yet RecruitingPrimary
Characterization of Pulp Inflammation: an Observational Study Using Biological Samples Collected During Routine Dental Care
NCT07330024Completed
Evaluation of Pulpal and Salivary Neuropeptides in Dental Pain
NCT07130214Active Not Recruiting
The Effect of Genetic Polymorphisms on the Success of Vital Pulp Therapy
NCT07108842Not ApplicableCompletedPrimary
Assessment of Pain Using Two Different Irrigation Systems After Root Canal Treatment
Showing all 4 trials